IART Short Volume
Integra LifeSciences Holdings Corporation (IART) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $1.43B, listed on NASDAQ, employing roughly 4,427 people, carrying a beta of 1.21 to the broader market. Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. Led by Stuart Essig, public since 1995-08-16.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-14
- Short Volume
- 142.3K
- Total Volume
- 168.3K
- Short %
- 84.55%
- 30-Day Avg Short %
- 70.92%
Showing 30 days of FINRA short volume data for Integra LifeSciences Holdings Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked IART short volume questions
- What is the daily IART short volume?
- As of Aug 14, 2026, Integra LifeSciences Holdings Corporation (IART) short volume is 142.3K shares against 168.3K total reported volume, or 84.55% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is IART short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does IART short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.